COMMUNIQUÉS West-GlobeNewswire

-
Boehringer Ingelheim and Zealand Pharma Advance Dual-Acting GLP-1/glucagon Agonist BI 456906 to Phase 2 Clinical Testing in Obesity/Diabetes
03/09/2019 -
Sandoz announces global deal to commercialize proposed biosimilar natalizumab, a key multiple sclerosis medicine
03/09/2019 -
ObsEva Reports New Clinical Evidence of Nolasiban Mechanism of Action, Supporting Its Potential to Increase Live Birth Rate Following Embryo Transfer in IVF
03/09/2019 -
argenx to Present at Morgan Stanley 17th Annual Global Healthcare Conference
03/09/2019 -
Santhera Announces Financial Results for the First Half-Year 2019
03/09/2019 -
Roche and Spark Therapeutics, Inc. announce extension of tender offer for shares of Spark Therapeutics, Inc.
03/09/2019 -
Afya Limited Issues Guidance for 2nd Half of 2019
03/09/2019 -
PROJECT HOPE GETS READY FOR HURRICANE DORIAN
02/09/2019 -
GENFIT: Board of Directors, Represented by Chairman Jean-François Mouney, Appoints Pascal Prigent as New CEO
02/09/2019 -
GENFIT : Au nom du Conseil d’Administration, son Président Jean-François Mouney annonce la nomination de Pascal Prigent au poste de nouveau Directeur Général
02/09/2019 -
Össur hf: Transactions in relation to share buyback program
02/09/2019 -
Information on total number of voting rights and shares composing the share capital as at August 31st, 2019
02/09/2019 -
Information relative au nombre total de droits de vote et d’actions composant le capital social au 31 août 2019
02/09/2019 -
Number of voting rights as of August 31, 2019
02/09/2019 -
Nombre de droits de vote au 31 août 219
02/09/2019 -
Odiparcil development advances with recruitment of first patients in a new biomarker study in MPS VI children and adults
02/09/2019 -
Inventiva - Le développement d’odiparcil progresse avec le recrutement des premiers patients dans une nouvelle étude biomarqueur menée chez des adultes et enfants atteints de la MPS VI
02/09/2019 -
IBA - Transparency notification
02/09/2019 -
IBA – PUBLICATION RELATIVE À UNE NOTIFICATION DE TRANSPARENCE
02/09/2019
Pages